Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozi
Not Applicable
Completed
- Conditions
- <tr><td>Albuminuria in patients with type 2 diabetes mellitus</td></tr>Type 2 diabetes mellitus, albuminuria, SGLT2 inhibitor, decentralized10012653
- Registration Number
- NL-OMON26308
- Lead Sponsor
- niversity Medical Center Groningen (UMCG)
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
|
- Leeftijd = 18 jaar |
Exclusion Criteria
|
- Diagnose type 1 diabetes |
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method